More than ten years ago, it was demonstrated that almost all insulinomas express several neuropeptide receptors, including CCK2 (cholecystokinin), VPAC1 (vasoactive intestinal peptide/PACAP receptor subtype 1) and GLP-1 (glucagon-like peptide 1) receptors4. The gene discussed is GLP1R; the disease is pancreatic insulinoma.